Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

Cyclophosphamide, methotrexate and fluorouracil adjuvant combination chemotherapy for breast cancer is currently used for the duration of six monthly courses. We performed a joint analysis of two studies on the duration of adjuvant cyclophosphamide, methotrexate and fluorouracil in patients with nod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Colleoni, M, Litman, H J, Castiglione-Gertsch, M, Sauerbrei, W, Gelber, R D, Bonetti, M, Coates, A S, Schumacher, M, Bastert, G, Rudenstam, C-M, Schmoor, C, Lindtner, J, Collins, J, Thürlimann, B, Holmberg, S B, Crivellari, D, Beyerle, C, Neumann, R L A, Goldhirsch, A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2002
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375405/
https://ncbi.nlm.nih.gov/pubmed/12087454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados